Patents by Inventor Alessandra Fierabracci

Alessandra Fierabracci has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SHORT INTERFERING RNA TARGETING VARIANT C1858T OF GENE PTPN22
    Publication number: 20210238607
    Abstract: The present invention concerns a short Interfering RNA, which is variant C1858T PTPN22 short interfering RNA duplexes (siRNA), and uses thereof in medical field in the prevention and treatment of autoimmune diseases.
    Type: Application
    Filed: May 8, 2019
    Publication date: August 5, 2021
    Applicant: Ospedale Pediatrico Bambino Gesu'
    Inventor: Alessandra FIERABRACCI
  • MICROVESICLES ISOLATED FROM MESENCHYMAL STEM CELLS FOR USE AS IMMUNOSUPPRESSIVE AGENTS
    Publication number: 20180140642
    Abstract: The present invention concerns microvesicles isolated from mesenchymal stem cells as immunosuppressive agents for treatment of inflammatory and immune pathologies.
    Type: Application
    Filed: June 29, 2017
    Publication date: May 24, 2018
    Inventors: Maurizio MURACA, Alessandra FIERABRACCI
  • MICROVESICLES ISOLATED FROM MESENCHYMAL STEM CELLS FOR USE AS IMMUNOSUPPRESSIVE AGENTS
    Publication number: 20140220053
    Abstract: The present invention concerns microvesicles isolated from mesenchymal stem cells as immunosuppressive agents for treatment of inflammatory and immune pathologies.
    Type: Application
    Filed: July 26, 2012
    Publication date: August 7, 2014
    Inventors: Maurizio Muraca, Alessandra Fierabracci
  • Method for detecting GAD65 autoreactive T cells newly diagnosed type1 diabetic patients and in the prediabetic period
    Publication number: 20070026465
    Abstract: The invention refers to a method for detecting GAD65 specific T cells in a biological sample useful for the prediction of T1D onset, and/or to follow up the effects of therapeutics and in particular of specific immunotherapies in the pre-clinical period of the disease.
    Type: Application
    Filed: July 25, 2006
    Publication date: February 1, 2007
    Inventors: Alessandra Fierabracci, Gian Bottazzo